157 related articles for article (PubMed ID: 27908215)
1. In vitro effect of myo-inositol on sperm motility in normal and oligoasthenospermia patients undergoing in vitro fertilization.
Artini PG; Casarosa E; Carletti E; Monteleone P; Di Noia A; Di Berardino OM
Gynecol Endocrinol; 2017 Feb; 33(2):109-112. PubMed ID: 27908215
[TBL] [Abstract][Full Text] [Related]
2. Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: in vivo study.
Gulino FA; Leonardi E; Marilli I; Musmeci G; Vitale SG; Leanza V; Palumbo MA
Gynecol Endocrinol; 2016; 32(1):65-8. PubMed ID: 26361940
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Mitochondrial Efficiency and DNA Oxidation in Human Sperm after In Vitro Myo-Inositol Treatment.
Governini L; Ponchia R; Artini PG; Casarosa E; Marzi I; Capaldo A; Luddi A; Piomboni P
J Clin Med; 2020 May; 9(6):. PubMed ID: 32481754
[TBL] [Abstract][Full Text] [Related]
4. Myoinositol: does it improve sperm mitochondrial function and sperm motility?
Condorelli RA; La Vignera S; Bellanca S; Vicari E; Calogero AE
Urology; 2012 Jun; 79(6):1290-5. PubMed ID: 22656408
[TBL] [Abstract][Full Text] [Related]
5. Sperm performance in oligoasthenoteratozoospermic patients is induced by a nutraceuticals mix, containing mainly myo-inositol.
Santoro M; Aquila S; Russo G
Syst Biol Reprod Med; 2021 Feb; 67(1):50-63. PubMed ID: 33094655
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of myo-inositol in the clinical management of patients with asthenozoospermia.
Dinkova A; Martinov D; Konova E
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):62-65. PubMed ID: 28724182
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen is a potent antioxidant modulator for sperm quality in patients with idiopathic oligoasthenospermia.
Guo L; Jing J; Feng YM; Yao B
Int Urol Nephrol; 2015 Sep; 47(9):1463-9. PubMed ID: 26216675
[TBL] [Abstract][Full Text] [Related]
8. Physiological Intra-Cytoplasmic Sperm Injection (PICSI) outcomes after oral pretreatment and semen incubation with myo-inositol in oligoasthenoteratozoospermic men: results from a prospective, randomized controlled trial.
Korosi T; Barta C; Rokob K; Torok T
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):66-72. PubMed ID: 28724183
[TBL] [Abstract][Full Text] [Related]
9. Analysis of MYO-Inositol effect on spermatozoa motility, in hyper viscous ejaculates and in patients with grades II and III varicocele.
Scarselli F; Lobascio AM; Terribile M; Casciani V; Greco P; Franco G; Minasi MG; Greco E
Arch Ital Urol Androl; 2016 Dec; 88(4):279-283. PubMed ID: 28073193
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant Effects of Myo-Inositol Improve the Function and Fertility of Cryopreserved Boar Semen.
Osman R; Lee S; Almubarak A; Han JI; Yu IJ; Jeon Y
Antioxidants (Basel); 2023 Aug; 12(9):. PubMed ID: 37759976
[TBL] [Abstract][Full Text] [Related]
11. [Seminal plasma anti-Müllerian hormone and inhibin B and serum inhibin B in predicting the outcome of routine IVF fertilization].
Wang YF; Wu X; Hu R; Wang FM; Jia ST; Pei LG; Wang H; Ouyang XE; Hu T; Fu YX
Zhonghua Nan Ke Xue; 2017 Nov; 23(11):991-996. PubMed ID: 29738164
[TBL] [Abstract][Full Text] [Related]
12. Effect of Myo-inositol on sperm quality and biochemical factors in cryopreserved semen of patients with Asthenospermia.
Azizi M; Cheraghi E; Soleimani Mehranjani M
Andrologia; 2022 Nov; 54(10):e14528. PubMed ID: 35841196
[TBL] [Abstract][Full Text] [Related]
13. Glutathione peroxidase activity in seminal plasma and its relationship to classical sperm parameters and in vitro fertilization-intracytoplasmic sperm injection outcome.
Crisol L; Matorras R; Aspichueta F; Expósito A; Hernández ML; Ruiz-Larrea MB; Mendoza R; Ruiz-Sanz JI
Fertil Steril; 2012 Apr; 97(4):852-7. PubMed ID: 22296823
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species, total antioxidant concentration of seminal plasma and their effect on sperm parameters and outcome of IVF/ICSI patients.
Hammadeh ME; Al Hasani S; Rosenbaum P; Schmidt W; Fischer Hammadeh C
Arch Gynecol Obstet; 2008 Jun; 277(6):515-26. PubMed ID: 18026972
[TBL] [Abstract][Full Text] [Related]
15. TAT-peroxiredoxin 2 Fusion Protein Supplementation Improves Sperm Motility and DNA Integrity in Sperm Samples from Asthenozoospermic Men.
Liu J; Zhu P; Wang WT; Li N; Liu X; Shen XF; Wang YW; Li Y
J Urol; 2016 Mar; 195(3):706-12. PubMed ID: 26585682
[TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation of antioxidants improves semen quality of IVF patients in terms of motility, sperm count, and nuclear vacuolization.
Wirleitner B; Vanderzwalmen P; Stecher A; Spitzer D; Schuff M; Schwerda D; Bach M; Schechinger B; Herbert Zech N
Int J Vitam Nutr Res; 2012 Dec; 82(6):391-8. PubMed ID: 23823924
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: a multi-centric study.
Canepa P; Dal Lago A; De Leo C; Gallo M; Rizzo C; Licata E; Anserini P; Rago R; Scaruffi P
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):7078-7085. PubMed ID: 30402876
[TBL] [Abstract][Full Text] [Related]
18. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study.
Safarinejad MR
Andrologia; 2011 Feb; 43(1):38-47. PubMed ID: 21219381
[TBL] [Abstract][Full Text] [Related]
19. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.
Rago R; Marcucci I; Leto G; Caponecchia L; Salacone P; Bonanni P; Fiori C; Sorrenti G; Sebastianelli A
J Biol Regul Homeost Agents; 2015; 29(4):913-23. PubMed ID: 26753656
[TBL] [Abstract][Full Text] [Related]
20. Advances in non-hormonal pharmacotherapy for the treatment of male infertility: the role of inositols.
Condorelli RA; Cannarella R; Crafa A; Barbagallo F; Gusmano C; Avola O; Mongioì LM; Basile L; Calogero AE; La Vignera S
Expert Opin Pharmacother; 2022 Jun; 23(9):1081-1090. PubMed ID: 35348407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
